
    
      Pulmonary arterial Hypertension is characterized by a progressive incerease in pulmonary
      vascular resistance(PVR) leading to right ventricualar failure.

      Udenafil inhibits PDE 5, an enzyme that metabolizes cGMP, enhancing the cGMP mediated
      relaxation and growth inhibition of vascular smooth muscle cells, including those in the
      lung.
    
  